PharmaTech

JANUARY 9, 2024

Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.

Manufacturing 52

Manufacturing Biopharma Pharma Sales 52

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Education 59

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Competition 87

Competition Biopharma Government Manufacturing 87

European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The first is removal of the RDP extension for pan-EU launch within two years, instead requiring manufacturers to submit to local P&MA processes upon request by the member state.

Biopharma 85

Biopharma Pharmaceutical Medicine Manufacturing 85

Fierce Pharma

JUNE 13, 2023

By: William Blake, Chief Technology Officer, Human-Based R&D | Danaher Life Sciences companies are ushering in a new era of engineering biology, partnering with biopharma leaders to deploy automation, AI and other engineering practices from early research through manufacturing.

Engineering 257

Engineering Biopharma Manufacturing 257

Pharmaceutical Technology

SEPTEMBER 8, 2022

With our proven track record in cancer immunotherapy, we are well-positioned to leverage our deep discovery, development, clinical, and manufacturing capabilities and worldwide reach to potentially bring innovative products from this programme to patients as fast as possible.”.

Biopharma 111

Biopharma Manufacturing Patients Pharma 111

Fierce Pharma

MAY 25, 2023

As drugmakers advance a wave of new cell and gene therapies, contract manufacturers have captured a larger share of the biopharma spotlight in recent years as they push to meet ever-increasing dema | As drugmakers advance a wave of new cell and gene therapies, contract manufacturers have captured a larger share of the biopharma spotlight in recent (..)

Biopharma 130

Biopharma Manufacturing 130

Pharmaceutical Technology

JULY 29, 2022

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.

Biopharma 59

Biopharma Manufacturing Government Engineering 59

Fierce Pharma

JULY 12, 2023

A new triumvirate of biopharma bigwigs is in line to reign over one of the industry’s top trade groups. | The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has unveiled the upcoming lineup for its CEO leadership team over the next two years.

Pharmaceutical manufacturing 246

Pharmaceutical manufacturing Biopharma Manufacturing Pharmaceutical 246

MedCity News

NOVEMBER 19, 2023

The German manufacturing site is the latest capital infrastructure move for Eli Lilly, which has already made $11 billion in investments in its global manufacturing capabilities in the past three years. The new site will help Lilly meet strong demand for its diabetes and obesity drugs.

Manufacturing 114

Manufacturing Biopharma Pharma 114

European Pharmaceutical Review

MAY 2, 2024

As a result, the market is expected to reach $719 billion by 2030, 1 Sigma Mostafa, PhD, Chief Scientific Officer at KBI Biopharma shared with EPR. These trends have an impact on manufacturing capacity. There are a lot of conjugated products in the clinical pipeline and novel conjugation partners and chemistries are being tried.

Medicine 99

Medicine Manufacturing Biopharma Engineering 99

PharmaTech

APRIL 30, 2023

Technical Projects, Capacity Expansion Pharma Production shares details of Baxter BioPharma Solution’s approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. In this podcast, Kayleigh Hearse, Sr Mgr.

Biopharma 40

Biopharma Manufacturing Pharma 40

European Pharmaceutical Review

NOVEMBER 30, 2023

o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans. Licensing of the manufacturing suites is expected in early 2024. So now we have a really nice blend.”

Manufacturing 77

Manufacturing Recruitment Medicine Biopharma 77

PharmaTech

APRIL 30, 2023

Technical Projects, Capacity Expansion Pharma Production shares details of Baxter BioPharma Solution’s approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. In this podcast, Kayleigh Hearse, Sr Mgr.

Biopharma 40

Biopharma Manufacturing Pharma 40

Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Iomab-B met the durable complete remission endpoint.

Manufacturing 59

Manufacturing Biopharma Pharmaceutical Pharma 59

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 130

Medicine Manufacturing Specialization Pharmaceutical 130

European Pharmaceutical Review

JANUARY 12, 2023

Out of 19 companies honoured with the 2022 Terra Carta Seal, the three pharma companies awarded were: GlaxoSmithKline PLC. Minimising the use of disposables in the manufacturing process through waste management and recycling. ” Biopharma successful in achieving climate-related goals, report finds.

Pharma 94

Pharma Biopharma Manufacturing Government 94

MedCity News

JANUARY 18, 2023

Cell therapy offers a treatment option for some advanced blood cancers, but the manufacturing process is lengthy and complex. The biopharmaceutical industry is working on various technologies that could make manufacturing faster and more efficient, or perhaps supplant the current process altogether.

Manufacturing 105

Manufacturing Biopharma Pharma 105

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 106

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 106

European Pharmaceutical Review

SEPTEMBER 14, 2023

This includes its Macclesfield campus, the UK’s largest pharma manufacturing site. The pharma company’s sites in Macclesfield, Cambridge, Luton and Speke will be supplied by energy from the biomethane facility. Supply of the renewable gas is planned through a new 15-year partnership with Future Biogas.

Manufacturing 103

Manufacturing Pharmaceutical manufacturing Medicine Pharma 103

Pharmaceutical Technology

NOVEMBER 30, 2022

However, efficiently manufacturing the drug represents another barrier to cross before realizing the full revenue potential then successfully. Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them.

Manufacturing 52

Manufacturing Pharmaceutical FDA Biopharma 52

Pharmaceutical Technology

MAY 9, 2023

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to private equity investor Advent International and growth investor Warburg Pincus, in a deal valued at $4.25bn in cash. The business will offer services from clinical research to commercial deployment for clients.

Manufacturing 97

Manufacturing Biopharma Pharma Healthcare 97

MedCity News

OCTOBER 10, 2023

Bayer opens its new cell therapy manufacturing facility as it prepares a Parkinson’s disease cell therapy for Phase 2 testing. The new 100,000 square foot facility also has space for manufacturing other cell therapies in the pharma giant’s pipeline.

Manufacturing 100

Manufacturing Pharma Biopharma 100

European Pharmaceutical Review

JULY 18, 2023

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. What is driving adoption of quality management systems in pharma? billion by 2030.

Marketing 95

Marketing Manufacturing Management Pharmaceutical manufacturing 95

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control.

Consulting 125

Consulting Biopharma Manufacturing Pharmaceutical 125

MedCity News

AUGUST 3, 2022

A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.

Pharma 82

Pharma Manufacturing Biopharma 82

pharmaphorum

DECEMBER 18, 2022

I outline below the salient aspects of a technology-driven patient access model, embraced as design principles, while designing and iterating a patient access platform with several large and small biopharma brands. The post Access solutions: the missing link that prevents biopharma innovation from reaching patients appeared first on.

Biopharma 87

Biopharma Patients Prescription Medical 87

Pharmaceutical Technology

JUNE 15, 2023

AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. Artificial intelligence (AI) has many implications for pharmaceutical companies, including on research, drug discovery and development, manufacturing and trials. Here are a few ways AI is used in pharma today.

Pharma 52

Pharma Management Networking Manufacturing 52

MedCity News

APRIL 13, 2023

Rejection of Eli Lilly’s mirikizumab means that two of the four drugs the pharma giant identified as revenue growth drivers for 2023 have failed to pass the regulatory bar. One of those drugs has been approved while the fourth drug still awaits an FDA decision.

FDA 101

FDA Manufacturing Pharma Biopharma 101

Clarivate

JULY 24, 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. The post Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023 appeared first on Clarivate.

Pharma 52

Pharma Biopharma Prospecting Training 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. Payer and/or manufacturer reporting.

Specialization 45

Specialization Leads Pharma Side effects 45

MedCity News

JULY 6, 2022

Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

Pharma 113

Pharma Consulting Patients Manufacturing 113

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

Pharmaceutical Technology

SEPTEMBER 13, 2022

The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This may best be achieved by large pharma companies, with their combined $200bn annual R&D budget, compared to smaller companies that are relying on external investment.

Biopharma 111

Biopharma Pharma Marketing Management 111

MedCity News

SEPTEMBER 24, 2023

Syntax Bio’s technology platform uses CRISPR to direct stem cells to become a desired cell type in a process that’s more scalable and less expensive than current methods. The startup is raising a Series A round of financing to further demonstrate the potential of its technology.

Manufacturing 125

Manufacturing Biopharma Pharma 125

Pharmaceutical Technology

JULY 6, 2022

Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. Caution in the near future.

Marketing 129

Marketing Biopharma Pharma Retail 129